You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
紅日藥業(300026.SZ)共有11個產品納入國家醫保目錄
格隆匯 11-28 16:41

格隆匯11月28日丨紅日藥業(300026.SZ)公佈,根據國家醫療保障局、人力資源和社會保障部公佈完整版的2019年《國家基本醫療保險、工傷保險和生育保險藥品目錄》,公司共有11個產品納入國家醫保目錄,其中甲類2個,乙類9個。

次公司產品必淨注射液被納入新版《國家醫保目錄》2019將使更多患者受益,也有利於促進該等產品的市場推廣和銷售,從長期看將對公司的經營業績產生積極的影響因新版《醫保目錄》於202011日起正式執行,不會對公司本報告期的經營業績構成重大影響。201963日,血必淨注射液治療重症肺炎的研究論文於在國際危重症醫學領域頂級期刊《重症醫學》(CCM)雜誌發表,標誌着該研究成果通過了國際同行專家嚴格審核並獲得一致認可。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account